Politico Cites Public Citizen Petition to FDA Calling for Stronger Warnings on Diabetes Medication

By Sarah Owermohle

“In a petition to the FDA, Public Citizen is urging the agency to require stronger warning labels for all SGLT2 inhibitor drugs — commonly used for Type 2 diabetes, but not approved for Type 1 — because they could be potentially fatal for Type 1 diabetes patients.”

 

Read the full story here.